share_log

華領醫藥-B：股份發行人的證券變動月報表

HUA MEDICINE-B: Monthly Return of Equity Issuer on Movements in Securities

HKEX ·  Jul 4 16:50

Summary by Futu AI

華領醫藥-B（02552.HK）於2024年7月4日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年6月30日的公司股份變動情況。報告顯示，華領醫藥的法定/註冊股本及已發行股份數量在該月份均無變動，維持在2,000,000,000股普通股，每股面值0.001美元，總股本為2,000,000美元。此外，公司的股份期權計劃亦無變動，首次公開發售後購股權計劃的股份期權數目保持在52,889,249股，可行使的股份總數為43,323,276股。報告期內，公司沒有進行任何股份的增發或減持，且所有證券發行或庫存股份的出售或轉讓均已獲得董事會的正式授權批准，並遵守相關的上市規則及法律規定。
華領醫藥-B（02552.HK）於2024年7月4日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年6月30日的公司股份變動情況。報告顯示，華領醫藥的法定/註冊股本及已發行股份數量在該月份均無變動，維持在2,000,000,000股普通股，每股面值0.001美元，總股本為2,000,000美元。此外，公司的股份期權計劃亦無變動，首次公開發售後購股權計劃的股份期權數目保持在52,889,249股，可行使的股份總數為43,323,276股。報告期內，公司沒有進行任何股份的增發或減持，且所有證券發行或庫存股份的出售或轉讓均已獲得董事會的正式授權批准，並遵守相關的上市規則及法律規定。
On July 4th, 2024, Hualing Medicine-B (02552.HK) submitted the latest monthly report on securities changes to Hong Kong Exchanges and Clearing Limited, reporting on the company's shareholding changes up to June 30th, 2024. The report shows that Hualing Medicine's statutory/registered share capital and issued share quantity remained unchanged in that month, maintaining 2,000,000,000 common shares with a par value of $0.001 per share, and a total share capital of $2,000,000. In addition, there were no changes to the company's share option plans, and the number of share options for the first public offering of share purchase rights remained at 52,889,249 shares, with a total exercisable share quantity of 43,323,276 shares. During the reporting period, the company did not issue any new shares or reduce its shareholding, and all sales or transfers of securities issued or inventory shares have been formally authorized and approved by the board of directors, and comply with relevant listing rules and legal requirements.
On July 4th, 2024, Hualing Medicine-B (02552.HK) submitted the latest monthly report on securities changes to Hong Kong Exchanges and Clearing Limited, reporting on the company's shareholding changes up to June 30th, 2024. The report shows that Hualing Medicine's statutory/registered share capital and issued share quantity remained unchanged in that month, maintaining 2,000,000,000 common shares with a par value of $0.001 per share, and a total share capital of $2,000,000. In addition, there were no changes to the company's share option plans, and the number of share options for the first public offering of share purchase rights remained at 52,889,249 shares, with a total exercisable share quantity of 43,323,276 shares. During the reporting period, the company did not issue any new shares or reduce its shareholding, and all sales or transfers of securities issued or inventory shares have been formally authorized and approved by the board of directors, and comply with relevant listing rules and legal requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated